Healthcare Executive Passes Out During Oval Office Announcement
Gordon Findlay, the Healthcare Executive of Novo Nordisk, fainted Thursday at the Oval Office amid a weight loss drug announcement.
Incident Details
The announcement, focused on GLP-1 drugs, was interrupted as Findlay lost consciousness. President Donald Trump and Dr. Mehmet Oz immediately noticed the situation.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted,” said White House Press Secretary Karoline Leavitt. “The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Background on the Announcement
On the same day, President Trump revealed an agreement with Eli Lilly and Novo Nordisk to offer some obesity drugs to Americans at roughly $150 per month.
Aftermath of the Fainting
- Multiple speakers addressed the White House audience before the incident.
- During Eli Lilly CEO David Ricks’ speech, Findlay passed out.
- The press was quickly evacuated while Dr. Kennedy left to provide medical help, according to Deputy Press Secretary Kush Desai.
- The press conference resumed by 1:29 p.m.
Summary
The unexpected fainting of Novo Nordisk's executive briefly paused the event announcing new affordable obesity drug deals, but medical staff quickly stabilized him and the event soon continued.
Would you like a version with more formal or simpler language?